Pharmaceutical microbiology is of crucial importance to the development and manufacture of pharmaceutical drugs, biologics and devices. Set to take place on the 21st and 22nd January 2015, the event will provide essential insights in to the latest advancements in practice and technology, developments in regulation and harmonisation of international practice and evolving methods and the latest technology
Join us as we explore key issues in data review and analysis, contamination control strategies, strategies for low endotoxin recovery and best practice in sterile and non-sterile manufacture. Hear presentations from the heart of industry, addressing real world case studies on the benefits and challenges of rapid methods, risk assessments and objectionable organisms. Share the wisdom of respected consultants and get the regulators perspective on recent changes and issues under review.
Benefits of Attending
- Discover the latest in the development and management of sterilisation and validation processes
- Benefit from shared learning and case studies to enhance your practice
- Understand data review and analysis for pharmaceutical microbiology
- Tune in to developments in bioburden and biofilm control strategies
- Look in depth at issues of objectionable organism management
- Hear specialist advice on contamination control and risk assessment
Plus Two Pre-Conference Half-Day Workshops | 20th January 2015
Methods for Endotoxin Detection and Removal8.30 - 12.30
Setting Up an Environmental Monitoring Programme to Meet Global Requirements13.30 - 18.00
Speakers
- Andrew Bartko, Research Leader, Battelle Memorial Institute
- Brian Hubka, CEO, BGH International
- Hans Noordergraaf, Microbiologist, Abbott Biologicals
- Jeanne Moldenhauer, Vice President, Excellent Pharma Consulting Inc
- Jim Polarine, Technical Service Manager, Steris Corporation
- Lada Laenen, Head of MSAT Cell Culture and Microbiology, Genzyme
- Olivier Chancel, Sterility and Aseptic Process Assurance Expert, Merial Sas
- Phil Duncanson, Director, QC Microbiology, MedImmune
- Robert Neri, Senior Scientist, Sanofi
- Ruth Daniels, Head of MSAT Microbiology, Genzyme Flanders N V / S A
- Sara Gamberini, Molecular Biology Scientist, Merck Serono - RBM
- Stephen Rawling, Microbiology Team Leader, GlaxoSmithKline
- Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca PLC
- Wolfgang Mutter, General Manager, Hyglos GmbH
The full agenda is not yet available for this event.
Follow this event to receive an alert when the agenda becomes available.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Who Should Attend
Chief Executives, Vice Presidents, Heads, Directors, Chief Scientists, Principle Scientists, and Project Leaders, Managers, in:
- Microbiologists
- Biological manufacture and production
- Quality control
- Quality assurance
- Antimicrobial and biocide research
- Biotech research and development
- Sterile lab management
- Sterile facilities design and construction
- Compliance
- Regulatory Affairs
- Validation
Venue
Marriott Hotel, Regents Park128 King Henry's Road
London, NW3 3ST
United Kingdom
